Full name
BOSTON SCIENTIFIC POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
BOSTON SCIENTIFIC POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ALEJA JANA PAWŁA II 22, 00-133 WARSZAWA
TAX ID5262110301
Rate company:
BOSTON SCIENTIFIC POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5262110301
KRS0000034717
Share capital1,004,000.00 zł
address
UL. ALEJA JANA PAWŁA II 22, 00-133 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5262110301
REGON
012401907
KRS
0000034717
Legal form
limited liability company
Register Address
UL. ALEJA JANA PAWŁA II 22, 00-133 WARSZAWA
Date of registration in KRS
2001-08-14
Date of commencement of economic activity
2001-08-14
Act signature
WA.XII NS-REJ.KRS/7597/25/715/ADE
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
33.13.Z - Repair and maintenance of electronic and optical devices
33.14.Z - Repair and maintenance of electrical devices
33.20.Z - Installation of industrial machinery, equipment, and devices
47.74.Z - Retail sale of medical and orthopedic products
73.11.Z - Advertising agency activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.99.Z - Other business support activities, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL02 1030 1508 0000 0008 1869 4001 
PL42 1880 0009 0000 0011 0243 2000 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 5,2 | 5,7 | 12,2 | 113,4 |
EBITDA | 12,1 | 18 | 26 | 44,6 |
Short time liabilities | 78,8 | 100,1 | 115,1 | 15 |
Equity capital | 26 | 29,8 | 39 | 31 |
Operating profit (EBIT) | 6,1 | 10,7 | 18,3 | 71,1 |
Assets | 122,6 | 150,1 | 173,6 | 15,6 |
Net profit (loss) | 4 | 3,8 | 9,2 | 142 |
Cash | 3,4 | 5,5 | 5,6 | 1,6 |
Net income from sale | 242,7 | 290,8 | 361,4 | 24,3 |
Liabilities and provisions for liabilities | 96,6 | 120,3 | 134,6 | 11,8 |
Working assets | 101 | 129,9 | 150,1 | 15,6 |
Depreciation | 6 | 7,3 | 7,7 | 5,9 |
% | % | % | p.p. | |
Profitability of capital | 15,3 | 12,8 | 23,7 | 10,9 |
Equity capital to total assets | 21,2 | 19,9 | 22,5 | 2,6 |
Gross profit margin | 2,1 | 2 | 3,4 | 1,4 |
EBITDA Margin | 5 | 6,2 | 7,2 | 1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 119 | 126 | 116 | -10 |
Current financial liquidity indicator | 1.1269806623458862 | 1.1495860815048218 | 0 | |
Net dept to EBITDA | 5.427607536315918 | 3.2988381385803223 | 2.8575551509857178 | -0,4 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (4)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Tuttomed Farmacja sp. z o.o.
Poznań
ELŻBIETA STĘPNIAK
Szczecin
CMS Polska sp. z o.o.
Rzeszów
Marek Mazurkiewicz
Zabrze
Gedeon Richter Polska sp. z o.o.
Grodzisk Mazowiecki
Gama Sp. z o.o.
Ruda Śląska
APTEKA ŚW. TOMASZA G. STOWSKA
Katowice
EUR-MED POLSKA
Katowice